Healthcare Global Enterprises Ltd operates in the Specialty hospitals exc. psychiatric sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Healthcare Global Enterprises Ltd with three other
health care providers in Asia:
INKON Life Technology Co Ltd
sales of 661.05 million Chinese Renmimbi [US$103.19 million]
of which 66%
was Medical services division),
Guangzheng Eye Hospital Group Co Ltd
(921.05 million Chinese Renmimbi [US$143.78 million]
of which 74%
was Medical and Health Care), and
Indraprastha Medical Corporation Limited
(8.31 billion Indian Rupees [US$113.23 million]
of which 100%
During the third
quarter of 2021, sales at Healthcare Global Enterprises Ltd totalled
2.73 billion Indian Rupees .
This is a drop of 1.5%
from the 2.77 billion Indian Rupees in sales at the company during the third quarter in 2020.
During the first three quarters of 2021, sales totalled 7.12 billion Indian Rupees , which is
than through the first three
quarters of 2020.
There appears to be at least some degree of seasonality in the sales at Healthcare Global Enterprises Ltd: during 4 of the previous 5
years, sales were highest during the fourth quarter.
The exception to this was during 2020, when the
second quarter was the best quarter, accounting for
25% of sales (during that same year, the
fourth quarter accounted for 25% of sales).
Healthcare Global Enterprises Ltd reported sales of 10.92 billion Indian Rupees (US$148.89 million)
March of 2020.
increase of 11.9%
versus 2019, when the company's sales were 9.76 billion Indian Rupees .
Sales at Healthcare Global Enterprises Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 110%).